Utah Retirement Systems reduced its stake in Clorox Company (The) (NYSE:CLX) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,621 shares of the company’s stock after selling 100 shares during the period. Utah Retirement Systems’ holdings in Clorox Company (The) were worth $3,148,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CLX. American Beacon Advisors Inc. bought a new stake in shares of Clorox Company (The) during the first quarter valued at about $104,000. Parkside Financial Bank & Trust increased its stake in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares during the last quarter. Valley National Advisers Inc. increased its stake in shares of Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. increased its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the last quarter. Finally, Zions Bancorporation increased its stake in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares during the last quarter. Institutional investors and hedge funds own 71.26% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) opened at 137.37 on Wednesday. The firm has a market capitalization of $17.73 billion, a price-to-earnings ratio of 25.75 and a beta of 0.40. The company has a 50-day moving average price of $134.18 and a 200-day moving average price of $134.70. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the previous year, the company posted $1.30 EPS. Clorox Company (The)’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities analysts forecast that Clorox Company will post $5.68 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.watchlistnews.com/clorox-company-the-clx-shares-sold-by-utah-retirement-systems/1531329.html.

CLX has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price objective on the stock in a research note on Tuesday, July 4th. BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research report on Thursday, May 4th. Barclays PLC reaffirmed an “equal weight” rating and issued a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Deutsche Bank AG reaffirmed a “hold” rating and issued a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Finally, Jefferies Group LLC set a $138.00 target price on Clorox Company (The) and gave the stock a “hold” rating in a research report on Wednesday, May 3rd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) has an average rating of “Hold” and a consensus price target of $129.05.

In other Clorox Company (The) news, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the transaction, the executive vice president now owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. Insiders own 0.74% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.